Consistently, Kapoor et al. found that intravenous immunoglobulin (IVIg) treatment effectively lowered serum neurofilament light chain (sNfL) levels in CIDP patients, bringing them closer to levels seen in healthy individuals [6]. This evidence concerns the gene NEFL and chronic inflammatory demyelinating polyradiculoneuropathy.